Gene · 5606
Papers2,515
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,515
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine. | Front Pharmacol | 2022 | 35721116 | PubTator, text mining | PubMed |
| RCAN1-mediated calcineurin inhibition as a target for cancer therapy. | Mol Med | 2022 | 35717152 | PubTator, text mining | PubMed |
| The landscape of isoform switches in sepsis: a multicenter cohort study. | Sci Rep | 2022 | 35715539 | PubTator, text mining | PubMed |
| Advances in Immunosuppressive Agents Based on Signal Pathway. | Front Pharmacol | 2022 | 35694243 | PubTator, text mining | PubMed |
| 4-phenylpyridine suppresses UVB-induced skin inflammation by targeting c-Src in vitro and in vivo. | J Cell Mol Med | 2022 | 35686492 | PubTator, text mining | PubMed |
| Anti-Inflammatory Mechanism of An Alkaloid Rutaecarpine in LTA-Stimulated RAW 264.7 Cells: Pivotal Role on NF-κB and ERK/p38 Signaling Molecules. | Int J Mol Sci | 2022 | 35682568 | PubTator, text mining | PubMed |
| Comparative Analysis of Gene Expression Patterns for Oral Epithelial Cell Functions in Periodontitis. | Front Oral Health | 2022 | 35677025 | PubTator, text mining | PubMed |
| Bayesian graphical models for modern biological applications. | Stat Methods Appt | 2022 | 35673326 | PubTator, text mining | PubMed |
| Structural and Functional Properties of Activator Protein-1 in Cancer and Inflammation. | Evid Based Complement Alternat Med | 2022 | 35664945 | PubTator, text mining | PubMed |
| Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection. | Acta Histochem | 2022 | 35662001 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Quantitative Proteomics Analysis for Better Understanding of Telomeric Zinc Finger-Associated Protein-Induced Pathogenesis in Cardiomyocytes. | Int Heart J | 2022 | 35650157 | PubTator, text mining | PubMed |
| Gamma synuclein promotes cancer metastasis through the MKK3/6-p38MAPK cascade. | Int J Biol Sci | 2022 | 35637967 | PubTator, text mining | PubMed |
| Inference of Molecular Regulatory Systems Using Statistical Path-Consistency Algorithm. | Entropy (Basel) | 2022 | 35626576 | PubTator, text mining | PubMed |
| FIP-fve Stimulates Cell Proliferation and Enhances IL-2 Release by Activating MAP2K3/p38α (MAPK14) Signaling Pathway in Jurkat E6-1 Cells. | Front Nutr | 2022 | 35614983 | PubTator, text mining | PubMed |
| Comparison of DNA Methylation Changes Between the Gestation Period and the After-Delivery State: A Pilot Study of 10 Women. | Front Nutr | 2022 | 35600817 | PubTator, text mining | PubMed |
| Plant Kinases in the Perception and Signaling Networks Associated With Arthropod Herbivory. | Front Plant Sci | 2022 | 35599859 | PubTator, text mining | PubMed |
| E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers. | Biochim Biophys Acta Rev Cancer | 2022 | 35589008 | PubTator, text mining | PubMed |
| Fenbendazole and its synthetic analog interfere with HeLa cells' proliferation and energy metabolism via inducing oxidative stress and modulating MEK3/6-p38-MAPK pathway. | Chem Biol Interact | 2022 | 35569513 | PubTator, text mining | PubMed |
| Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand? | Cancers (Basel) | 2022 | 35565385 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5606/papers?page=18